Lilly begins first clinical trial of antibody that targets SARS-CoV-2

Monday, June 1, 2020 - 18:00 in Health & Medicine

The antibody, isolated by the Canadian start-up AbCellera, was discovered and developed in just 3 months

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net